Page last updated: 2024-08-22

sizofiran and ovalbumin

sizofiran has been researched along with ovalbumin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aoshi, T; Ishii, KJ; Kobiyama, K; Mochizuki, S; Morishita, H; Sakurai, K1
Ki, CS; Kim, H; Lee, S1

Other Studies

2 other study(ies) available for sizofiran and ovalbumin

ArticleYear
Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Dec-28, Volume: 220, Issue:Pt A

    Topics: Adjuvants, Immunologic; Animals; Antigen-Presenting Cells; Cancer Vaccines; Cells, Cultured; Immunization; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Mice, Inbred C57BL; Neoplasms; Oligodeoxyribonucleotides; Ovalbumin; Peptide Fragments; Sizofiran; Spleen; T-Lymphocytes, Cytotoxic; Tissue Distribution; Tumor Burden

2015
Modular formation of hyaluronic acid/β-glucan hybrid nanogels for topical dermal delivery targeting skin dendritic cells.
    Carbohydrate polymers, 2021, Jan-15, Volume: 252

    Topics: Administration, Cutaneous; Animals; beta-Glucans; Cell Line; Dendritic Cells; Drug Carriers; Hyaluronic Acid; Immunologic Factors; Immunomodulation; Methacrylates; Mice; Nanogels; Ovalbumin; Proof of Concept Study; Sizofiran; Skin Absorption; Swine

2021